Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Nasopharyngeal Carcinoma, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Nasopharyngeal Neoplasms, Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Skin Neoplasms, Thymoma, Thymus Neoplasms, Colorectal Neoplasms, Adenocarcinoma, Clear Cell, Triple Negative Breast Neoplasms

NCT06328673 2025-12-24

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Phase 1 Active not recruiting

160 enrolled

Other solid neoplasm

Advanced Solid Tumor

Clinical Trials

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

MVX-ONCO-2 in Advanced Solid Tumors

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors

A Monotherapy in Subjects With Advanced Solid Tumors

A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

REST

A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors

A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

KEYNOTE-603

Study of E7389 Liposomal Formulation in Participants With Solid Tumor

QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations

A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours

Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

SUMMIT-1

GK01IIT-TZ03

Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors

Study of GS-4528 in Adults With Solid Tumors

A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors

A Study of FDA018-ADC in Patients With Advanced Solid Tumors

Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors

A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions

A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors

Phase I Comparative Bioavailability Study

Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors

A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)

A Study of SGN-MesoC2 in Advanced Solid Tumors

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors

A Study of FL115 Monotherapy in Unresectable or Metastatic Solid Tumors

EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors